Trial Profile
A phase II study of amrubicin for previously treated small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Amrubicin (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 05 Mar 2009 New trial record.